Tech Company Financing Transactions

Celsense Funding Round

Private investors participated in a $248 thousand funding round for Celsense. This venture round was announced by the company on 12/31/2015.

Transaction Overview

Company Name
Announced On
12/31/2015
Transaction Type
Debt
Amount
$248,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 16 investors participated in the offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
603 Stanwix St. 348
Pittsburgh, PA 15222
USA
Email Address
Overview
Out of business.
Profile
Celsense LinkedIn Company Profile
Social Media
Celsense Company Twitter Account
Company News
Celsense News
Facebook
Celsense on Facebook
YouTube
Celsense on YouTube

Management Team

Title
Name
Email & Social
Chairman
Paul Kornblith
  Paul Kornblith LinkedIn Profile  Paul Kornblith Twitter Account  Paul Kornblith News  Paul Kornblith on Facebook
Chief Executive Officer
Charles O'Hanlon
  Charles O'Hanlon LinkedIn Profile  Charles O'Hanlon Twitter Account  Charles O'Hanlon News  Charles O'Hanlon on Facebook
Chief Scientific Officer
Eric Ahrens
  Eric Ahrens LinkedIn Profile  Eric Ahrens Twitter Account  Eric Ahrens News  Eric Ahrens on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2015: Sandlot Solutions venture capital transaction
Next: 1/4/2016: Applied Cavitation venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary